Rohan Steel, PhD, is a project leader in the Biological Research Unit at Racing Analytical Services, Ltd. (RASL), in Flemington, Australia.

Michael Barkan is a senior informatics consultant at CSols Inc., a North American laboratory informatics consultancy with offices in Canada and the US.

Theodore Price, PhD,  talks to contributing editor Tanuja Koppal, PhD, about the advent of digital cell imaging instruments that are very mobile, user-friendly, inexpensive, and intuitive to work with.

Dr. Paula Rose discusses her work with IRMS in a new lab at Texas A&M University.

Stephen Bustin, PhD talks about the persisting problem of lack of transparency and reliability in current PCR data.

Annie Pathiparampil is an analytical chemist at Chevron Energy Technology Company in Richmond, California. At her work, her main focus area is in classical wet chemistry methods, including ion chromatography.

Zhuoyi Huang, PhD, postdoctoral associate in the laboratory of Dr. Fuli Yu, at the Human Genome Sequencing Center, Baylor College of Medicine, talks to contributing editor Tanuja Koppal, PhD, about the work they have been doing to address the computational challenges associated with analysis of high throughput next-generation sequencing (NGS) data.

Associate editor Rachel Muenz speaks with research scientists Freya Freestone, MChem, and Helen O'Shea, BSc about data processing, analysis, and managing workflows in the lab.

Lab Manager's Tanuja Koppal discusses microbiome research with Georg K. Gerber, assistant professor of pathology at Harvard Medical School

Josephine Ferreon is an assistant professor in the Department of Pharmacology, Baylor College of Medicine in Houston, Texas. Her structural biology group characterizes various intrinsically disordered proteins (IDPs), important in stem cell biology and neurodegenerative diseases, using standard and state-of-the-art biochemical/biophysical techniques such as NMR and single molecule fluorescence spectroscopy.

Serge Cremers, Pharm. D., PhD, is an associate professor at Columbia University Medical Center and an attending clinical chemist at New York Presbyterian Hospital. He is the director of the Clinical Pharmacology and Toxicology Laboratory at Columbia University Medical Center and the director of the Biomarkers Core Laboratory of the Irving Institute for Clinical and Translational Research, which is home to Columbia University’s Clinical and Translational Science Award (CTSA) and the largest mass spectrometry facility at Columbia University, focusing on targeted metabolomics and the measurement of drugs. Dr Cremers’ areas of expertise are bio-analytical chemistry, translational and clinical pharmacology, therapeutic drug monitoring, as well as clinical chemistry of metabolic bone diseases. He conducts research in all of these areas and has published over 90 papers. 

Michael Rummel has held the position of chief operating officer at InSource Diagnostics, an independent laboratory that focuses on medication monitoring and compliance testing, for several years. Since graduating from the University of Wisconsin-Madison in 2005, Michael has pursued a career working in the analytical and clinical sciences. He has expertise in analytical chemistry assay development specifically with liquid chromatography/mass spectrometry, assay optimization, and sample preparation optimization and development.